Jiangsu Kanion Pharmaceutical Co Ltd (600557) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.041x

Based on the latest financial reports, Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥201.83 Million ≈ $29.53 Million USD) by net assets (CN¥4.91 Billion ≈ $718.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jiangsu Kanion Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Jiangsu Kanion Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Jiangsu Kanion Pharmaceutical Co Ltd (600557) total liabilities for a breakdown of total debt and financial obligations.

Jiangsu Kanion Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Kanion Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
SMA SOLAR T. UNSP.ADR/01
F:S93
N/A
B.Grimm Power Public Company Limited
BK:BGRIM
0.092x
Harbin Gloria Pharmaceuticals
SHE:002437
0.084x
Inner Mongolia ERDOS Resources Co Ltd B
SHG:900936
0.083x
Netcare
JSE:NTC
0.220x
Wuxi Online Offline Communication Information Technology Co. Ltd.
SHE:300959
N/A
SUFA Technology Industry Co Ltd CNNC
SHE:000777
0.002x
Lindblad Expeditions Holdings Inc
NASDAQ:LIND
-0.152x

Annual Cash Flow Conversion Efficiency for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Kanion Pharmaceutical Co Ltd from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see 600557 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥4.71 Billion
≈ $688.50 Million
CN¥702.49 Million
≈ $102.80 Million
0.149x -17.38%
2023-12-31 CN¥5.38 Billion
≈ $787.34 Million
CN¥972.32 Million
≈ $142.28 Million
0.181x -10.47%
2022-12-31 CN¥4.93 Billion
≈ $722.00 Million
CN¥995.94 Million
≈ $145.74 Million
0.202x -0.60%
2021-12-31 CN¥4.47 Billion
≈ $654.50 Million
CN¥908.30 Million
≈ $132.91 Million
0.203x +25.32%
2020-12-31 CN¥4.33 Billion
≈ $633.14 Million
CN¥701.10 Million
≈ $102.59 Million
0.162x -28.45%
2019-12-31 CN¥4.09 Billion
≈ $598.12 Million
CN¥925.73 Million
≈ $135.46 Million
0.226x +38.52%
2018-12-31 CN¥3.89 Billion
≈ $569.56 Million
CN¥636.39 Million
≈ $93.12 Million
0.164x +53.44%
2017-12-31 CN¥3.59 Billion
≈ $525.84 Million
CN¥382.93 Million
≈ $56.03 Million
0.107x +14.25%
2016-12-31 CN¥3.21 Billion
≈ $469.11 Million
CN¥299.02 Million
≈ $43.76 Million
0.093x -47.99%
2015-12-31 CN¥2.87 Billion
≈ $420.08 Million
CN¥514.80 Million
≈ $75.33 Million
0.179x +47.14%
2014-12-31 CN¥2.56 Billion
≈ $374.06 Million
CN¥311.54 Million
≈ $45.59 Million
0.122x -39.25%
2013-12-31 CN¥1.93 Billion
≈ $283.08 Million
CN¥388.11 Million
≈ $56.79 Million
0.201x +56.12%
2012-12-31 CN¥1.65 Billion
≈ $241.54 Million
CN¥212.11 Million
≈ $31.04 Million
0.129x +110.14%
2011-12-31 CN¥1.47 Billion
≈ $215.81 Million
CN¥90.19 Million
≈ $13.20 Million
0.061x -54.27%
2010-12-31 CN¥1.24 Billion
≈ $182.08 Million
CN¥166.40 Million
≈ $24.35 Million
0.134x +759.34%
2009-12-31 CN¥1.08 Billion
≈ $157.77 Million
CN¥-21.87 Million
≈ $-3.20 Million
-0.020x -133.16%
2008-12-31 CN¥954.72 Million
≈ $139.71 Million
CN¥58.39 Million
≈ $8.54 Million
0.061x -63.20%
2007-12-31 CN¥557.95 Million
≈ $81.65 Million
CN¥92.73 Million
≈ $13.57 Million
0.166x -24.83%
2006-12-31 CN¥492.91 Million
≈ $72.13 Million
CN¥108.98 Million
≈ $15.95 Million
0.221x -0.20%
2005-12-31 CN¥457.89 Million
≈ $67.00 Million
CN¥101.44 Million
≈ $14.84 Million
0.222x +323.09%
2004-12-31 CN¥414.10 Million
≈ $60.60 Million
CN¥21.68 Million
≈ $3.17 Million
0.052x +14.61%
2003-12-31 CN¥374.88 Million
≈ $54.86 Million
CN¥17.13 Million
≈ $2.51 Million
0.046x +36.56%
2002-12-31 CN¥333.38 Million
≈ $48.78 Million
CN¥11.15 Million
≈ $1.63 Million
0.033x -88.24%
2001-12-31 CN¥73.91 Million
≈ $10.82 Million
CN¥21.02 Million
≈ $3.08 Million
0.284x --

About Jiangsu Kanion Pharmaceutical Co Ltd

SHG:600557 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.11 Billion
CN¥7.60 Billion CNY
Market Cap Rank
#8686 Global
#2284 in China
Share Price
CN¥13.43
Change (1 day)
-0.37%
52-Week Range
CN¥12.72 - CN¥19.83
All Time High
CN¥33.10
About

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 a… Read more